Paricalcitol
Back to searchMolecule Structure
Scientific Name
Paricalcitol
Description of the Drug
Paricalcitol is a vitamin D analog used to treat hyperparathyroidism associated with stage 3 or greater chronic kidney disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00910
http://www.drugbank.ca/drugs/DB00910
Brand Name(s)
Paricalcitol, Zemplar
Company Owner(s)
Lotus Pharmaceutical Co Ltd Nantou Plant, Amneal Pharmaceuticals Co Gmbh, Sandoz Inc, Hospira Inc, Accord Healthcare Inc, Hikma Pharmaceuticals Co Ltd, Abbvie Inc, Dr Reddys Laboratories Ltd, Eugia Pharma Specialities Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Vitamin D receptor | SINGLE PROTEIN | AGONIST | CHEMBL1977 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3655 | |
| PharmGKB | PA450798 | |
| Human Metabolome Database | HMDB0015046 | |
| DrugBank | DB00910 | |
| PubChem: Thomson Pharma | 14880085 | 14758016 |
| PubChem | 5281104 | |
| LINCS | LSM-45519 | |
| Nikkaji | J1.157.530G | |
| BindingDB | 233195 | |
| EPA CompTox Dashboard | DTXSID4048640 | |
| LipidMaps | LMST04030163 | |
| DrugCentral | 2066 | |
| ChemicalBook | CB0500520 | |
| Guide to Pharmacology | 2791 | |
| rxnorm | ZEMPLAR | PARICALCITOL |
| PubChem: Drugs of the Future | 12015105 | |
| KEGG Ligand | C08127 | |
| ChEBI | 7931 | |
| ZINC | ZINC000013911941 |
